• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific escapes fraud case

Boston Scientific escapes fraud case

September 21, 2011 By MassDevice staff

Boston Scientific

A federal judge in Massachusetts tossed a shareholders’ lawsuit accusing Boston Scientific Corp. (NYSE:BSX) of fraudulently concealing problems within its cardiac rhythm management division that prompted it to fire several members of its CRM sales force.

Judge Douglas Woodlock of the U.S. District Court for Massachusetts granted the Natick, Mass.-based medical device maker’s motion to dismiss the case, ruling that BSX seemed "diligent, rather than fraudulent or reckless" in its handling of the CRM disaster it inherited with its Guidant Corp. acquisition in 2006.

The suit accused Boston Scientific, former CEO James Tobin, his replacement Ray Elliott and COO Sam Leno of hiding Guidant’s problems between April 20, 2009, and March 12, 2010. Citing filings with the federal Securities & Exchange Commission and statements the executives made in press releases and during conference calls with analysts, the suit alleged that the men and the company made calculated, falsely rosy statements about the division designed to artificially boost Boston Scientific’s share prices.

Sign up to get our free newsletters delivered right to your inbox

It also cited the November 2009 departure of the CRM division’s senior sales and marketing executive, William McConnell Jr., and Elliott’s move to cashier several BoSci sales staff and managers from its CRM division in Minnesota.

But, according to Woodlock, the company did well in handling the problems within the CRM sales force. Citing an internal audit begun in August 2009 to pore over "the expenses incurred for food and entertainment provided to physicians during trips to certain of Boston Scientific’s manufacturing facilities, and to determine whether these expenses complied with ethical guidelines,” according to court documents. That probe led to a weeks-long interrogation of 21 members of the CRM sales force – and to the eventual firings of several of them for "violation of the company’s ethical policies," according to the documents.

"Among the sales personnel terminated during that time period was Douglas Nock, one of the three Division Vice Presidents for CRM sales,” Woodlock wrote. “Nock was then hired by a competitor, St. Jude Medical, where he began working on January 4, 2010. Defendants did not disclose publicly the existence of the internal audit and the resulting dismissal of certain CRM sales personnel until the close of trading on February 10, 2010.”

(In fact, several of the fired sales staffers wound up with St. Jude Medical (NYSE:STJ), prompting some harsh words from BSX CEO Ray Elliott and a tart reply from STJ.)

"Fairly read, the complaint portrays [Boston Scientific] as being diligent, rather than fraudulent or reckless, when it chose to conduct an internal audit, just one month after the AdvaMed Code of Ethics was put into place, and then decided to terminate sales personnel who repeatedly breached its healthcare professional Code of Conduct,” Woodlock wrote. “The company knew the terminations of CRM sales representatives may have a cost, yet chose to move forward with the process. The disclosure by Defendants of the terminations and their potential impact on the company’s future revenues only two months after these terminations took place was ‘reasonable time,’ which was ‘necessary to get things right.’"

Filed Under: Legal News, News Well Tagged With: Boston Scientific, Guidant Corp.

More recent news

  • Neuronetics names Steven Pfanstiel chief financial officer
  • Medtronic to distribute Future Medical’s peripheral guidewires
  • AtriCure completes enrollment in stroke prevention trial
  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy